Matches in Wikidata for { <http://www.wikidata.org/entity/Q65542771> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q65542771 description "clinical trial" @default.
- Q65542771 description "ensayu clínicu" @default.
- Q65542771 description "klinisch onderzoek" @default.
- Q65542771 description "клінічне випробування" @default.
- Q65542771 name "Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs" @default.
- Q65542771 name "Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs" @default.
- Q65542771 type Item @default.
- Q65542771 label "Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs" @default.
- Q65542771 label "Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs" @default.
- Q65542771 prefLabel "Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs" @default.
- Q65542771 prefLabel "Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs" @default.
- Q65542771 P1132 Q65542771-8B8C9CB0-1108-486D-A079-010D965A3B20 @default.
- Q65542771 P1476 Q65542771-48A143B3-7547-473D-98B8-5A3754DB959B @default.
- Q65542771 P17 Q65542771-151FA163-3FA7-4BF6-A0DD-9BFECC7BA631 @default.
- Q65542771 P17 Q65542771-1ED2C40B-D4D8-45C4-BFD7-20F5F48DE99D @default.
- Q65542771 P17 Q65542771-21556A3F-7ECE-4A52-BB03-2564A0D94D86 @default.
- Q65542771 P17 Q65542771-57C98EFC-8BD5-4E97-98B2-30FD45930D5D @default.
- Q65542771 P17 Q65542771-6356D86E-E90F-4C2D-BDBF-B9B2B41727E9 @default.
- Q65542771 P17 Q65542771-64E83E5D-06D1-429F-AAF6-92DC730DE6B1 @default.
- Q65542771 P17 Q65542771-6600FC07-FCB4-432F-8FAA-948B2A2B84B8 @default.
- Q65542771 P17 Q65542771-72B5E3F0-A84A-4795-970B-BC1A49E922B1 @default.
- Q65542771 P17 Q65542771-985E5817-E303-45B9-A0B1-1DCEBA98C077 @default.
- Q65542771 P17 Q65542771-C2903C18-0C6B-4AAF-8757-75A72F253FD0 @default.
- Q65542771 P17 Q65542771-E774E7C4-A663-4205-97D6-6B0DC1D99BED @default.
- Q65542771 P2899 Q65542771-D6681B4A-B658-4768-A403-C1C80277E1A9 @default.
- Q65542771 P3098 Q65542771-0CC23813-1B97-4FC4-AC85-230CAE9751F9 @default.
- Q65542771 P31 Q65542771-AD13E0A8-204C-42D2-ADF5-281F60DA6C1E @default.
- Q65542771 P4844 Q65542771-2166159E-A36D-454C-9486-569D0E559172 @default.
- Q65542771 P580 Q65542771-A5407C81-DA9E-486B-A61A-2B8903DFB60D @default.
- Q65542771 P582 Q65542771-E3615708-AE8A-49C1-A7C9-D6460CA57C87 @default.
- Q65542771 P6099 Q65542771-B0F7DB0C-65C8-49BC-9F1C-D271F4C132E0 @default.
- Q65542771 P8363 Q65542771-771FC762-6E6D-4EE2-92BC-1365FE4F6958 @default.
- Q65542771 P1132 "+276" @default.
- Q65542771 P1476 "Efficacy of Esomeprazole 40 mg Once Daily Versus Placebo or Esomeprazole 20 mg Once Daily Versus Placebo in Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs Including COX-2 Selective NSAIDs" @default.
- Q65542771 P17 Q145 @default.
- Q65542771 P17 Q16 @default.
- Q65542771 P17 Q20 @default.
- Q65542771 P17 Q213 @default.
- Q65542771 P17 Q214 @default.
- Q65542771 P17 Q258 @default.
- Q65542771 P17 Q30 @default.
- Q65542771 P17 Q34 @default.
- Q65542771 P17 Q36 @default.
- Q65542771 P17 Q38 @default.
- Q65542771 P17 Q408 @default.
- Q65542771 P2899 "+18" @default.
- Q65542771 P3098 "NCT00241553" @default.
- Q65542771 P31 Q30612 @default.
- Q65542771 P4844 Q27282619 @default.
- Q65542771 P580 "2001-04-01T00:00:00Z" @default.
- Q65542771 P582 "2003-02-01T00:00:00Z" @default.
- Q65542771 P6099 Q42824827 @default.
- Q65542771 P8363 Q78089383 @default.